People · Operator
Named in public records as an officer, director or promoter · active 2019–2023 · Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Replicel Life Sciences Inc. | — | Other Technology | Pre-Seed | $5.5M | $869K | 2019 |
ROLF HOFFMANN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ROLF HOFFMANN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| DAVID HALL | 1 | 8 |
| Geoff MacKay | 1 | 5 |
| Peter Lewis | 1 | 4 |
| PETER JENSEN | 1 | 3 |
| TOM KORDYBACK | 1 | 2 |
| Jamie Mackay | 1 | 1 |
| David Kwok | 1 | 1 |
| Ben Austring | 1 | 1 |
| Gary Boddington | 1 | 1 |
| Lee Buckler | 1 | 1 |
| Andrew Schutte | 1 | 1 |
| Kevin McElwee | 1 | 1 |
| SIMON MA | 1 | 1 |
| PETER LOWRY | 1 | 1 |
| LARISSA HUANG | 1 | 1 |
| GAVIN YE | 1 | 1 |
| HUGH ROGERS | 1 | 1 |
| PETER RICHARD GEORGE LEWIS | 1 | 1 |
| GEOFF RICHARD GEORGE MACKAY | 1 | 1 |
| JOHN RICHARD GEORGE CHALLIS | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.